Dr. Schuchter: Changing How Cancer is Treated

(1:41)

Dr. Schuchter Discusses the Treatment of Melanoma

(1:32)

Dr. Schuchter on the Progression of Melanoma Care

(49)

Dr. Schuchter Discusses Managing Ipilimumab's Side Effects

(40)

Dr. Schuchter on the Next Steps in Melanoma Research

(32)

Dr. Schuchter: An Exciting Future

(13)

Lynn M. Schuchter, MD -- Medical Oncologist at Penn Medicine

(1:52)

Lynn Schuchter Sees `Epidemic' of Melanoma

(3:38)

Dr. Schuchter on Testing for a BRAF Mutation in Melanoma

(1:4)

Dr. Schuchter Reserves BRAF Testing for Advanced Melanoma

(51)

Dr. Schuchter: What is Immunotherapy?

(1:35)

Research about Immunotherapy as Cancer Treatment

(8:21)

Dr. Schuchter: Who Benefits from Immunotherapy?

(28)

Dr. Schuchter: Role of the Immune System

(47)

Dr. Schuchter: How Does Immunotherapy Work?

(1:17)

Dr. Schuchter Describes Two Trials Looking at Nivolumab in Melanoma

(1:17)

Some Informations About Tata Medical Center Kolkata | Tata Cancer Hospital Kolkata | W For Wellness

(8:6)

Strand Campus tour | King's College London

(7:1econd)

Dr. Lynn Schuchter Discusses Two Trials Looking at Nivolumab in Melanoma

(1:7)

Dr. Schuchter: Clinical Trials

(1:37)

HemOnc Lynn Schuchter

(2:23)

Dr.Schuchter: How Long Does Immunotherapy Take to Work

(1:33)